Cover Image

Cereblon: A promising E3 ligase for broad-spectrum anticancer PROTAC drug development?

Saved in:

Bibliographic Details
Main Authors:	Wenxin Fang (Author), Ruolan Zhang (Author), Jianhui Liang (Author), Wanrong Xie (Author), Youtao Zhang (Author), Lei Chen (Author), Yan Wang (Author)
Format:	Book
Published:	Elsevier, 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges?
by: Marcin Cieślak, et al.
Published: (2023)

PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective
by: Xin Han, et al.
Published: (2022)

Model based assessment of food and acid reducing agent effects on oral absorption of mezigdomide (CC‐92480), a novel cereblon E3 ligase modulator
by: Fan Wu, et al.
Published: (2023)

Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency. Case Series and Review of the Literature
by: Aidé Tamara Staines Boone, et al.
Published: (2019)

Alkylphospholipids - A Promising Class of Chemotherapeutic Agents with a Broad Pharmacological Spectrum
by: Juliana de Almeida Pachioni, et al.
Published: (2013)

E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential
by: Yuanqi Liu, et al.
Published: (2021)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
by: Sinan Ma, et al.
Published: (2022)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
by: Arvind Negi, et al.
Published: (2022)

Synthesis of Second-Generation Analogs of Temporin-SHa Peptide Having Broad-Spectrum Antibacterial and Anticancer Effects
by: Arif Iftikhar Khan, et al.
Published: (2024)

Cereblon Deficiency Contributes to the Development of Elastase-Induced Emphysema by Enhancing NF-κB Activation
by: Eun-Young Heo, et al.
Published: (2022)

Broad-Spectrum Antimicrobial, Antioxidant, and Anticancer Studies of Leaf Extract of <i>Simarouba glauca</i> DC In Vitro
by: Shanmuga Priya Ramasamy, et al.
Published: (2022)

PROTACs targeting epigenetic proteins
by: Chao Zhang, et al.
Published: (2023)

Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity
by: Ashraf K. El-Damasy, et al.
Published: (2023)

Application of PROTACs in target identification and validation
by: Yang Liu, et al.
Published: (2024)

dsRNA as broad-spectrum antiviral therapeutics
by: Congfei Xu
Published: (2022)

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity
by: Junhe Bao, et al.
Published: (2023)

The role of SCF ubiquitin-ligase complex at the beginning of life
by: Jiayan Xie, et al.
Published: (2019)

Characteristics of doripenem: a new broad-spectrum antibiotic
by: Francisco Alvarez-Lerma, et al.
Published: (2009)

Broad-spectrum therapeutics: A new antimicrobial class
by: Anton Firth, et al.
Published: (2021)

PROTACs for BRDs proteins in cancer therapy: a review
by: Chao Wang, et al.
Published: (2022)

Comparative Efficacy Between Intense Pulsed Light Narrow Spectrum and Broad Spectrum in the Treatment of Post-Acne Erythema (PAE)
by: Al-Quran L, et al.
Published: (2023)

Computational strategies for PROTAC drug discovery
by: Jia Wu, et al.
Published: (2023)

Degradation of proteins by PROTACs and other strategies
by: Yang Wang, et al.
Published: (2020)

PROTACs: Walking through hematological malignancies
by: Lara J. Bou Malhab, et al.
Published: (2023)

Are we ready to design oral PROTACs®?
by: Diego Garcia Jimenez, et al.
Published: (2021)

Broad-spectrum ginsentides are principal bioactives in unraveling the cure-all effects of ginseng
by: Shining Loo, et al.
Published: (2024)

Comment on: Target-based discovery of a broad-spectrum flukicide.
by: Timir Tripathi
Published: (2024)

Broad spectrum integration of climate change in health sciences curricula
by: Oladele A. Ogunseitan
Published: (2022)

Poly-Target Selection Identifies Broad-Spectrum RNA Aptamers
by: Khalid K. Alam, et al.
Published: (2018)

Size-Controlled Ammonium-Based Homopolymers as Broad-Spectrum Antibacterials
by: Meltem Haktaniyan, et al.
Published: (2023)

HAZ, a novel peptide with broad-spectrum antibacterial activity
by: Mohammad Alsaggar, et al.
Published: (2022)

Lipophosphonoxins-A Novel Group of Broad Spectrum Antibacterial Compounds
by: Viktor Šebek, et al.
Published: (2023)

Changes in the Serum Metabolome of Patients Treated With Broad-Spectrum Antibiotics
by: George Eugene Jaskiw, et al.
Published: (2020)

Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation
by: Liang Jiang, et al.
Published: (2021)

PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
by: Peiyi Zhang, et al.
Published: (2020)

Development of Liposome Systems for Enhancing the PK Properties of Bivalent PROTACs
by: Ponien Kou, et al.
Published: (2023)

PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
by: Yulu Zhang, et al.
Published: (2024)

An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment
by: Yuzhu Zhang, et al.
Published: (2022)

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
by: Jeremy Hall, et al.
Published: (2024)

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
by: Si-Min Qi, et al.
Published: (2021)